Deferred Tax Assets, Valuation Allowance of Sonoma Pharmaceuticals, Inc. from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • Sonoma Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $29,062,000, a 5.8% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $29,062,000 -$1,774,000 -5.8% 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q1 2024 $30,836,000 +$27,000 +0.09% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q1 2023 $30,809,000 +$196,000 +0.64% 31 Mar 2023 10-K 17 Jun 2024 2024 FY
Q1 2022 $30,613,000 -$915,000 -2.9% 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q1 2021 $31,528,000 -$3,769,000 -11% 31 Mar 2021 10-K 13 Jul 2022 2022 FY
Q1 2020 $35,297,000 +$125,000 +0.36% 31 Mar 2020 10-K 14 Jul 2021 2021 FY
Q1 2019 $35,172,000 +$2,799,000 +8.6% 31 Mar 2019 10-K 10 Jul 2020 2020 FY
Q1 2018 $32,373,000 -$9,683,000 -23% 31 Mar 2018 10-K 01 Jul 2019 2019 FY
Q1 2017 $42,056,000 -$2,550,000 -5.7% 31 Mar 2017 10-K 26 Jun 2018 2018 FY
Q1 2016 $44,606,000 +$719,000 +1.6% 31 Mar 2016 10-K 28 Jun 2017 2017 FY
Q1 2015 $43,887,000 +$2,614,000 +6.3% 31 Mar 2015 10-K 21 Jun 2016 2016 FY
Q1 2014 $41,273,000 +$82,981,000 31 Mar 2014 10-K 16 Jun 2015 2015 FY
Q1 2013 $41,708,000 -$391,000 -0.95% 31 Mar 2013 10-K 30 Jun 2014 2014 FY
Q1 2012 $41,317,000 31 Mar 2012 10-K 25 Jun 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.